DANIPHARM A/S: Financial statements 2016
CVR: 12335040
Source: annual report 2016, Danish Business Authority
01/07/2015 – 30/06/2016
DANIPHARM A/S (CVR 12335040) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 85,172,061 and a net result of DKK 15,240,178 compared with DKK 11,265,725 the year before. That is an increase of 0.1% compared with the year before. The profit margin was 17.9%. Equity in the 2016 report amounted to DKK 41,755,764. The solvency ratio was 74.5%. The company had 22 employees in the financial year.
- Revenue
- DKK 85,172,061
- Gross Profit
- DKK 40,851,460
- Profit/Loss
- DKK 15,240,178
- Equity
- DKK 41,755,764
- Total Assets
- DKK 56,014,642
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 85.2 mio. | 40.9 mio. | 15.2 mio. | 41.8 mio. | 22 |
| 2015 | 85.1 mio. | 34.9 mio. | 11.3 mio. | 26.5 mio. | 23 |
| 2014 | 90.1 mio. | 30.9 mio. | 8.9 mio. | 15.3 mio. | 23 |
| 2013 | 84.8 mio. | 21.9 mio. | 232 t. | 6.4 mio. | 21 |
Official annual report
Find more companies like DANIPHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout DANIPHARM A/S
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Niels Ulrik Heine (chair), Helle Rørvig and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity in the 2025 report amounted to DKK 60,280,949.